(19)
(11) EP 0 417 196 A1

(12)

(43) Date of publication:
20.03.1991 Bulletin 1991/12

(21) Application number: 89906953.0

(22) Date of filing: 23.05.1989
(51) International Patent Classification (IPC): 
G01N 33/ 53( . )
C07K 7/ 08( . )
C07K 14/ 52( . )
C07K 14/ 76( . )
C07K 16/ 24( . )
C12N 5/ 10( . )
C12P 21/ 08( . )
C12R 1/ 91( . )
 A61K 39/ 395( . )
C07K 14/ 00( . )
C07K 14/ 54( . )
C07K 16/ 00( . )
C07K 19/ 00( . )
C12N 15/ 02( . )
G01N 33/ 577( . )
(86) International application number:
PCT/US1989/002152
(87) International publication number:
WO 1989/011489 (30.11.1989 Gazette 1989/28)
(84) Designated Contracting States:
AT BE CH DE FR GB IT LI LU NL SE

(30) Priority: 26.05.1988 US 19880199110

(71) Applicant: Schering Biotech Corporation
Palo Alto California 94304-1104 (US)

(72) Inventors:
  • ABRAMS, John, S.
    Belmont, CA 94002 (US)
  • PEARCE, Michael, K.
    Palo Alto, CA 94306 (US)

(74) Representative: Ritter, Stephen David, et al 
Mathys & Squire 100 Grays Inn Road
London WC1X 8AL
London WC1X 8AL (GB)

   


(54) IMMUNOGENIC HUMAN INTERLEUKIN-3 PEPTIDE AND MONOCLONAL ANTIBODIES THERETO